7 Patents
- US126126182026Nucleobase Editors Having Reduced Non-target Deamination and Assays for Characterizing Nucleobase Editors
Beam Therapeutics Inc.
0 cites - US126009712026Modified Immune Cells Having Adenosine Deaminase Base Editors for Modifying a Nucleobase in a Target Sequence
BEAM THERAPEUTICS Inc.
0 cites - US121338842024Methods of Substituting Pathogenic Amino Acids Using Programmable Base Editor Systems
Beam Therapeutics Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites